Guangdong VTR Bio-Tech Co., Ltd. signed an agreement to acquire 51% stake in World-Way Biotech Inc. from Zeng Jianguo, Zeng Jianzhong, Zeng Jianxiang and Zeng Jianming for CNY 85.7 million.
January 15, 2017
Share
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) signed an agreement to acquire 51% stake in World-Way Biotech Inc. from Zeng Jianguo, Zeng Jianzhong, Zeng Jianxiang and Zeng Jianming for CNY 85.7 million on January 13, 2017. For the year ended December 31, 2016, World-Way Biotech Inc. reported total assets of CNY 105.9 million, net assets of CNY 78.03 million, revenue of CNY 50.4 million, operating profit of CNY 2.04 million, and net profit of CNY 1.4 million. The transaction is subject to approval of shareholders' of Guangdong VTR Bio-Tech Co., Ltd. The Board of Guangdong VTR Bio-Tech Co., Ltd. approved the transaction on January 13, 2017.
Guangdong VTR Bio-Tech Co Ltd is a China-based company mainly engaged in biotechnology services. The Company is mainly engaged in the research and development, production, sales and service of bioenzyme preparations, biosynthetic products and nutrition and health products, and provides customers with overall biotechnology solutions. The bioenzyme preparations are used in many fields such as feed, food, energy, pharmaceuticals, textiles, papermaking, environmental protection, brewing, starch sugar, detergents and health products. The biosynthetic products include medicines, food, feed, cosmetics, medical devices, and others. The nutrition and health products are mainly animal nutrition and health products, including feed additives, plant extracts, and others.
Guangdong VTR Bio-Tech Co., Ltd. signed an agreement to acquire 51% stake in World-Way Biotech Inc. from Zeng Jianguo, Zeng Jianzhong, Zeng Jianxiang and Zeng Jianming for CNY 85.7 million.
GUANGDONG VTR BIO-TECH CO., LTD. 
